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1. Introduction 
Branch retinal vein occlusion (BRVO) is a common vascular disorder that is frequently 
associated with severe vision loss due to its complications. There are two forms of BRVO, the 
ischaemic and the non-ischemic, both leading to loss of visual acuity. About 20-30% of the 
BRVOS are ischemic and the majority of them develop secondary glaucoma and rubeosis. [1] 
Although this disorder was first reported by J. von Michel in 1878, its pathogenesis has still not 
been fully understood, and no effective therapy has been developed for this disorder [1-3]. 
Comparative research on this disorder is based on clinical models of BRVO.  
The pathological features of BRVO can be more accurately reproduced by a photodynamic 
method to induce thrombosis in retinal vessels[4–14] than by using other methods such as laser 
coagulation[15–17], electrocoagulation of the retinal vein via the vitreous body[18], intravenous 
thrombin instillation[19–21] and endothelin-I injection into the posterior vitreous body[22, 23]. In 
the photodynamic method, a photosensitizing agent, namely, rose Bengal, is injected 
intravenously. This dye absorbs light maximally at a specific wavelength of 550 nm. Dye 
activation in the presence of molecular oxygen leads to the generation of singlet oxygen, which 
in turn acts locally to injure or destroy the vascular endothelium. The altered endothelium 
provides a surface for platelet aggregation and subsequent thrombosis. By using this method, 
thrombi can be produced in vessels. Because relatively low light intensities are required to 
initiate this process, the thermal effects on the surrounding tissues are minimized.  
In this investigation, we used a Xenon arc lamp as the light source, and visible light was 
transmitted through an intraocular fiber to induce BRVO in pigmented rabbits. The 
characteristics of BRVO were evaluated quantitatively, and histological studies were 
performed to support the clinical findings. The results provided  a framework for future 
applications of this technique. 
2. Materials and methods  
2.1 Animals and husbandry 
Thirty-two male Standard Chinchilla rabbits were purchased from the Experimental Animal 
Center of Tianjin Medical University (Tianjin, China) and allowed to acclimate upon arrival 
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for 10 d before the initiation of the experiment. At the beginning of the study, the animals 
were aged 3–4 months and weighed 2.5–3.5 kg. All experimental animals were housed in 
individual cages under stable environmental conditions: diet, commercial pellet diet 
(Lushifu, Beijing, China) and tap water ad libitum; relative humidity, 45–55%; temperature, 
18°C; and light-dark cycle, 12/12 h (intensity, 300 lux).  
The study was approved by the Ethics Committee of Tianjin medical university. All animal 
experiments were performed in accordance with the conventions of the Association for 
Research in Vision and Ophthalmology (ARVO) for ethics in animal experimentation.  
2.2 Experimental design 
The 32 rabbits (32 eyes, 32 vessels) were randomly divided into 15 treatment groups (n = 2) 
and 1 control group (n = 2). The treatment groups were administered 5 different rose Bengal 
doses (3, 6, 9, 12 and 15 mg/kg) and exposed to light of 3 different intensities (600, 1000 and 
1400 lux) 1 min later. In the control group rabbits, the vessels were exposed to a light 
intensity of 1400 lux for 20 min without injection of the rose Bengal dye. 
2.3 Experimental procedure 
In preparation for the treatment and follow-up examinations, the rabbits were fully 
anesthetized with an intramuscular injection of 60 mg/kg ketamine (Beijing Shuanghe 
Pharmaceuticals, Beijing, China) and 8 mg/kg xylazine (Beijing Shuanghe Pharmaceuticals, 
Beijing, China). The pupils were dilated using 0.5% tropicamide eye drops (Beijing 
Shuanghe Pharmaceuticals, Beijing, China).  
Rose Bengal (tetrachloro-tetraiodo-fluorescein sodium; certified purity, 90%; Sigma, St. 
Louis, MO) was dissolved in normal saline (30 mg/ml), sterilized by passage through a 0.22-
µm filter and injected intravenously in doses of 3, 6, 9, 12 or 15 mg/kg before the light 
treatment. A Xenon arc lamp (Anshijia Instrument Co. Ltd., Beijing, China) was used as a 
light source, and light was transmitted by using a 0.2-mm intraocular illumination fiber 
(Alcon (China) Ophthalmic Product Co. Ltd., Shanghai, China). Light intensity was 
measured using a digital lux meter (LX-9621; Landtek Instrument Co. Ltd., Guangzhou, 
China). Average values of 600, 1000 and 1400 lux, for the low, medium and high settings, 
respectively, were obtained with less than 3% variation in repeated measurements 
throughout the study. 
According to the treatment protocol, the rabbits were placed on a stage under a surgical 
microscope (OPTON Universal S3; Germany). 2% methylcellulose solution (Zhengda Co. Ltd., 
Shandong, China) is dropped on the cornea to couple the input light into the 30-degree prism 
lens (Anshijia Instrument Co. Ltd., Beijing, China). The operations were observed by using a 
contact lens and a surgical microscope. A 25-gauge trocar (Alcon (China) Ophthalmic Product 
Co. Ltd., Shanghai, China) was used to make an incisions in the conjunctiva and sclera at the 
projection holes located supratemporally 3 mm from the corneal limbus, then the needle was 
removed and the intraocular fiber was inserted through the incision and its direction was 
toward optic disc, the depth was 10 mm. Rose Bengal was injected intravenously through the 
marginal ear vein. After 1 min, the trunk vessels adjacent to the optic disc of 1~ 3 mm were 
exposed to a beam of white light. The duration of continuous exposure to light did not exceed 
20 min, and the exposure time was recorded if complete vascular occlusion was observed. The 
fiber finally was then taken out and the sclera was finally sutured. 
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Fundus fluorescein angiography (FFA) was performed using a fundus camera (Zeiss FF450IR; 
Carl Zeiss Far East Co. Ltd., Beijing, China) before the treatment and everyday after the 
treatment until the occluded vein reopened. The 5 mg aqueous fluorescein sodium (100 
mg/ml, Baiyunshan Pharmaceuticals Co. Ltd., Guangzhou, China) was injected into ear veins 
immediately prior to FFA under anesthesia and pupil dilation those were as same as the prior. 
2.4 Experimental observation  
The rate and duration of vessel occlusion are confirmed with an ophthalmoscope and by 
FFA. The blood flow was confirmed by a scleral depressor transiently applied pressure on 
the equator of the eyeball, thereby the higher intraocular pressure (IOP) reduced the flow 
rate until freely moving red blood cells were seen. Once the scleral depressor was removed, 
a rapid uninterrupted column of blood flow passed through without the presence of 
stagnant red blood cells. [9] These dynamic phenomenons were monitored by an 
ophthalmoscope and it was the character of reperfused vessels. 
When reperfusion was noted on post-treatment day 1, the number of days of occlusion was 
defined as 0. When the vessel was observed to be occluded on day 1 but not on day 2, the 
number of days of occlusion was defined as 1 and so on. 
Two rabbits in the control group and 1 rabbit in the treatment groups in whom BRVO was 
confirmed by FFA were euthanized using intravenous overdose of pentobarbital sodium 
(Beijing Shuanghe Pharmaceuticals, Beijing, China). Their eyes were enucleated and 
prepared for light microscopic examination by using standard techniques. Sections (5-µm-
thick) were stained with haematoxylin/eosin. The remaining rabbits were euthanized by 
administering an overdose of pentobarbital sodium at the end of the experiment.  
2.5 Statistical analysis  
A partial correlation coefficient was used to analyze the relationship between the time of 
thrombosis, the drug dose, and light intensity. A P value of 0.05 or less was considered 
statistically significant. All data were analysed with the SPSS 11.5 software. 
3. Results 
3.1 Evaluation of BRVO animal model 
BRVO models were developed in 22 of the 30 rabbits in the treatment group. The fundus 
could be observed in detail by using a surgical microscope (please see supplemental video 
1). In the site exposed to light, photodynamic injury resulted in white debris (plaque-like 
thrombi) and the stagnation of blood flow. FFA showed the engorged distal ends of the 
venules proximal to the occlusion site and peripheral retinal oedema in the BRVO area 
(Figure 1).  
Histological sections were studied to confirm the presence and extent of the photodynamic 
lesions. Retinal vein damage was confined to the area of direct light exposure in the treatment 
groups. Histological examination revealed thrombi consisting of platelet aggregates, stagnant 
red blood cells and a few white blood cells. Occluded retinal vein histological section indicated 
that compact thrombus filled the entire vein cavity and occlusion is evident. (Figure 2).  
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Fig. 1. Photodynamic thrombosis of a branch retinal vein in a pigmented rabbit eye. Initial 
formation of a thrombosis in the target vein (A) and complete obliteration of the vessel 
lumen (B). FFA showed a delay in the time required for angiosclerosis in the distal end of 
the vein and discontinuous intravenous blood flow in the vicinity of the optic disc (C). 
Arrows indicate the occlusion site and peripheral retinal oedema. 
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Fig. 2. Histological findings. Two hours after thrombosis, the thrombus filled the entire 
vein cavity (long arrow), and the artery was normal (short arrow). The thrombus consisted 
of platelet aggregates, stagnant red blood cells and a few white blood cells. Magnification, 
200×. 
The control vessels and the blood flow through them were as same as those in healthy 
animals. The histological sections from the rabbits that were not injected with rose Bengal 
showed no evidence of photochemical or thermal retinal damage in the site that was 
exposed to a light intensity of 1400 lux (maximum light intensity) for 20 min. 
3.2 Dose- and light-response studies 
Vein occlusion in the pigmented rabbits was considered as the end point for determining 
dose- and light-response relationships. In 22 successful BRVO models, the time required to 
produce an occlusion decreased with an increase in the dose of rose Bengal administered 
and the light intensity. Rose Bengal at doses of more than 9 mg/kg was effective in 
producing BRVO; a dose of 6 mg/kg was ineffective in producing BRVO at a light intensity 
of 600 lux. At a dose of 3 mg/kg, small plaques also developed in the target vessel; however, 
they did not progress to vascular occlusions in 20 min even if the light intensity was as high 
as 1400 lux. The total light energy required to produce an occlusion increased from an 
average of 600 lux with 9 mg/kg of rose Bengal to 1000 lux with 6 mg/kg of rose Bengal. 
The time of occurrence of thrombosis showed a negative correlation with the drug dose and  
light intensity. A decrease in the time required for the development of BRVO corresponded 
to a higher drug dose (partial r = –0.7895; P < 0.001) and a higher light intensity (partial  
r = –0.9060; P < 0.001) (Figure 3).  
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Fig. 3. The relationship between the time required for thrombosis and the dose of rose 
Bengal and the light intensity. The mean value of the time required for thrombosis was 
determined (n = 2). Complete BRVO formation did not occur when a dose of 3 mg/kg rose 
Bengal was used, and a dose of 6 mg/kg rose Bengal was ineffective in producing BRVO at 
a light intensity of 600 lux.  
3.3 Duration of occlusion 
In the early period of BRVO in the animal models, FFA and fundus photography 
documented the blood along the circuitous expanded vein, and retinal oedema that was 
similar to the lesion in humans. The area of the white thrombus gradually decreased with 
time, and the angiostenosis in the distal end of the retinal vein also gradually decreased. In 
21 cases, the minimum duration record for the reopening of an occlusion was 3 d and the 
maximum, 10 d (Figure 4).  
 
 
Fig. 4. The frequency of the duration of vessel occlusion. The duration of BRVO varied 
from 3 to 10 d. The data correspond to a Gaussian distribution (P < 0.01); the 95% confidence 
bound was 4.73–6.03 d, and the mean duration of vessel occlusion was 5.38 ± 1.43 d (n = 21). 
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While developing an animal model, the following factors should be considered: the animal 
species used, the ease of development and reproducibility of the model and the degree of 
similarity of the model with the human disease. In this study, we focus on optimizing the 
method used to induce experimental thrombosis.  
The animal species that are usually selected for the development of BRVO animal models 
are mouse, rat, rabbit, cat, pig, dog and monkey. Mice[14] and rats[5–7, 9] are suitable for the 
development of large numbers of RVO models for research because of their low price, easy 
availability and breeding management. Further, these models enable easy identification of 
the retinal artery and vein. However, the eye of mice or rats is too small to permit 
investigative surgical procedures. The structure of the retina in pigs[12, 15], cats[8] or dogs[4] is 
similar to that in humans except that it does not have a macular region. The retinal blood 
supply in rhesus monkeys[16, 17] is similar to that in human; however, the sources of these 
animals are limited, and they are difficult to breed and manage. Compared with the eyeballs 
of other animal species, the rabbit eyeball is sufficiently large to operate[19–23]. Further, 
rabbits are inexpensive, can be easily bred and the FFA of the rabbit eye is stable. Therefore, 
we selected pigmented rabbits for our study.  
The combination of intraocular fibre illumination with the administration of rose Bengal 
should be classified as a photodynamic method of inducing BRVO because the wavelength 
of visible light include 550 nm. These findings correspond to Virchow’s hypothesis of 
thrombosis in humans. Compared with the photodynamic method, laser coagulation[15–17] 
requires higher energy and a longer exposure time, which would inevitably result in heat 
injury and disruption of the vessel wall, and subsequently, frequent bleeding. 
Electrocoagulation of the retinal vein via the vitreous body[18] utilizes electrothermal energy 
to destroy the vascular endothelium and block the vessels, which is different from the 
process of thrombosis. In intravitreous thrombin instillation method[19–21], the location of the 
retinal thrombus could not be determined; thus, the thrombus may occlude other regions 
but not the target vessels. The injection of endothelin-I into the posterior vitreous body[22, 23] 
caused complete occlusion of the temporal retinal vessels, but this vasospastic mechanism is 
also unsuitable for application in the experimental induction of thrombosis because actual 
clinical BRVO was occluded at one or some spots in vein.  
Presently, an argon (Ar) laser is often used as the excitation light source in the 
photodynamic method because its wavelength of 514 nm is similar to the light absorption 
peak of rose Bengal. However, heat injury from laser-coagulation to the retinal tissue and its 
vessels is observed. Moreover, due to the pulsed excitation of the laser, continuous exposure 
of the vessel to the laser beam is impossible. Consequently, it is difficult to adjust the level of 
energy used in this procedure: if the energy level is too low, no thrombus formation occurs 
and if it is too high, vessel hemorrhage occurs[8]. Some researchers utilize common light 
sources such as slit lamps and Xenon lamps to develop BRVO animal models. However, the 
use of these light sources resulted in an extensive arteriovenous obstruction caused due to 
the exposure of a large area to the light source, therefore, these light sources are not suitable 
for studying a typical BRVO[9, 10, 13]. In a previous study, we use a microsurgical illumination 
system, which comprised a 0.9-mm intraocular fibre that served as an endoilluminator to 
produce RVO in pigs[11]; the intraocular fibre illuminated the nearby retinal vascular target 
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and by localizing energy, it is able to produce a thrombus as effectively as laser irradiation. 
However, the diameter of the retinal trunk vein in rabbits was only 150–200 µm, and the 
microsurgical system was too wide to the rabbit. Therefore, in this study, we used a Xenon 
arc lamp as a light source and designed a 0.2 mm fiber for illumination to ensure that the 
light beam irradiate the trunk vein and not the accompanying artery. We find that this is a 
simple and reliable system for developing BRVO models in rabbits.  
The process of formation of BRVO in our rabbit model can be visualized and photographed 
using a surgical microscope. At the site exposed to light, the following course of 
thrombogenesis is recognized: photodynamic injury resulted in a decrease in the rate of 
venous blood flow; this is followed by the appearance of stagnant red blood cells in the 
vessel, the gradual accumulation of white debris (plaque-like thrombi) and the development 
of a vascular occlusion. The distal ends of the venules are engorged proximal to the 
occlusion site. The morphological and histopathological changes are similar to Kohner’s 
results[24]. No changes were observe in the light microscopic images of the control vessels; 
this confirmes that illumination do not produce heat injury in the retinal vessels and tissue.  
The dose- and light-response studies show that the time of occurrence of thrombosis 
correlate negatively with the drug dose and light intensity; further, the basic set of 
parameters require to produce an occlusion is an average light intensity of 600 lux, a rose 
Bengal dose of 9 mg/kg and an exposure time of 11.5 min or an average light intensity of 
1000 lux, a rose Bengal dose of 6 mg/kg and an exposure time of 6.75 min. Thus, we suggest 
that the optimum parameters should be 1000 lux, 9 mg/kg of rose Bengal and an exposure 
time of 3–5 min. This suggestion is based on the following considerations: the experimental 
dose of rose Bengal in this model is maintained as low as possible to prevent the leakage of 
rose Bengal into the vitreous humour and the anterior chamber[12]; the energy level of the 
light used to induce thrombosis is higher than that in the breeding conditions (300 lux); this 
ensures that thrombosis occur only in the area exposed to the light and not in other vessels. 
On the other hand, the exposure time of 3–5 min was suitable for operation. The 
optimization of this method may aid investigators in controlling thrombus formation more 
precisely. 
Clinical BRVO is a disease of long duration and various types [1-3]; however, the 
experimental occlusion is maintained for 3 to 10 d (average, 5.38 d) in our model. This may 
be attributed to the use of young and healthy experimental animals, the sudden generation 
of an obstruction in the normal vascular bed and the activation of an autochthonous repair 
mechanism; all these factors result in rapid thrombolysis. Therefore, this BRVO model is 
very suitable for observation of immediate therapy experiment, for example, surgery; and 
not suitable for long-term drug treatment studies.  
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